An Open Label study to examine the effects of DAS181 adm

Project: Research project

Project Details

Description

An Open Label study to examine the effects of DAS181 administered by Dry Powder Inhaler (DPI) or Nebulized formulation in Immunocompromised subjects with Parainfluenza (PIV) Infection
StatusActive
Effective start/end date8/13/1312/31/20

Funding

  • ANSUN BIOPHARMA, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.